Kathryn C. Zoon - 25 May 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
25 May 2021
Net transactions value
-$177,291
Form type
4
Filing time
27 May 2021, 16:37:50 UTC
Previous filing
24 May 2021
Next filing
25 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $177,291 -3,139 -18% $56.48* 14,377 25 May 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
F2 All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
F3 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.